Abstract

Secreted isoform of endoplasmic reticulum membrane complex subunit 10 (scEMC10) is a poorly characterized secreted protein of largely unknown physiological function. Here we demonstrate that scEMC10 is upregulated in people with obesity and is positively associated with insulin resistance. Consistent with a causal role for scEMC10 in obesity, Emc10-/- mice are resistant to diet-induced obesity due to an increase in energy expenditure, while scEMC10 overexpression decreases energy expenditure, thus promoting obesity in mouse. Furthermore, neutralization of circulating scEMC10 using a monoclonal antibody reduces body weight and enhances insulin sensitivity in obese mice. Mechanistically, we provide evidence that scEMC10 can be transported into cells where it binds to the catalytic subunit of PKA and inhibits its stimulatory action on CREB while ablation of EMC10 promotes thermogenesis in adipocytes via activation of the PKA signalling pathway and its downstream targets. Taken together, our data identify scEMC10 as a circulating inhibitor of thermogenesis and a potential therapeutic target for obesity and its cardiometabolic complications.

Secreted isoform of endoplasmic reticulum membrane complex subunit 10 (scEMC10) is a secreted protein of incompletely understood physiological function. Here the authors show that scEMC10 is upregulated in people with obesity, and that that genetic EMC10 deletion or antibody-based neutralization of EMC10 prevents diet-induced obesity in mice.

Details

Title
Secreted EMC10 is upregulated in human obesity and its neutralizing antibody prevents diet-induced obesity in mice
Author
Wang, Xuanchun 1   VIAFID ORCID Logo  ; Li, Yanliang 2 ; Qiang, Guifen 3   VIAFID ORCID Logo  ; Wang, Kaihua 4 ; Dai, Jiarong 1   VIAFID ORCID Logo  ; McCann, Maximilian 5   VIAFID ORCID Logo  ; Munoz, Marcos D. 6 ; Gil, Victoria 6   VIAFID ORCID Logo  ; Yu, Yifei 1 ; Li, Shengxian 7 ; Yang, Zhihong 8 ; Xu, Shanshan 6 ; Cordoba-Chacon, Jose 9   VIAFID ORCID Logo  ; De Jesus, Dario F. 10   VIAFID ORCID Logo  ; Sun, Bei 11 ; Chen, Kuangyang 1 ; Wang, Yahao 1 ; Liu, Xiaoxia 1 ; Miao, Qing 1 ; Zhou, Linuo 1 ; Hu, Renming 1 ; Ding, Qiang 12 ; Kulkarni, Rohit N. 10   VIAFID ORCID Logo  ; Gao, Daming 13   VIAFID ORCID Logo  ; Blüher, Matthias 14   VIAFID ORCID Logo  ; Liew, Chong Wee 6   VIAFID ORCID Logo 

 Fudan University, Department of Endocrinology, Huashan Hospital, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443) 
 Fudan University, Department of Endocrinology, Huashan Hospital, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443); University of Illinois at Chicago, Department of Physiology & Biophysics, Chicago, USA (GRID:grid.185648.6) (ISNI:0000 0001 2175 0319); University of Illinois at Chicago, Department of Ophthalmology and Visual Sciences, Chicago, USA (GRID:grid.185648.6) (ISNI:0000 0001 2175 0319) 
 University of Illinois at Chicago, Department of Physiology & Biophysics, Chicago, USA (GRID:grid.185648.6) (ISNI:0000 0001 2175 0319); Chinese Academy of Medical Sciences and Peking Union Medical College, State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Beijing, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839) 
 Chinese Academy of Sciences, State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai, China (GRID:grid.9227.e) (ISNI:0000000119573309); University of Chinese Academy of Sciences, Beijing, China (GRID:grid.410726.6) (ISNI:0000 0004 1797 8419) 
 University of Illinois at Chicago, Department of Physiology & Biophysics, Chicago, USA (GRID:grid.185648.6) (ISNI:0000 0001 2175 0319); University of Illinois at Chicago, Department of Ophthalmology and Visual Sciences, Chicago, USA (GRID:grid.185648.6) (ISNI:0000 0001 2175 0319) 
 University of Illinois at Chicago, Department of Physiology & Biophysics, Chicago, USA (GRID:grid.185648.6) (ISNI:0000 0001 2175 0319) 
 University of Illinois at Chicago, Department of Physiology & Biophysics, Chicago, USA (GRID:grid.185648.6) (ISNI:0000 0001 2175 0319); Shanghai Jiao Tong University, Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293) 
 Harvard Medical School, Research Division, Joslin Diabetes Center, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Harvard Medical School, Department of Transplant Surgery, Mass General Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
 University of Illinois at Chicago, Department of Medicine, Section of Endocrinology, Diabetes and Metabolism, Chicago, USA (GRID:grid.185648.6) (ISNI:0000 0001 2175 0319) 
10  Harvard Medical School, Research Division, Joslin Diabetes Center, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
11  Tianjin Medical University, NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228) 
12  Fudan University, Department of Urology, Huashan Hospital, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443) 
13  Chinese Academy of Sciences, State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai, China (GRID:grid.9227.e) (ISNI:0000000119573309); University of Chinese Academy of Sciences, Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, Hangzhou, China (GRID:grid.410726.6) (ISNI:0000 0004 1797 8419) 
14  University of Leipzig, Department of Medicine, Leipzig, Germany (GRID:grid.9647.c) (ISNI:0000 0004 7669 9786) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2740752815
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.